PRC1 and hepatocellular carcinoma: miR-194 targets the protein regulator of cytokinesis 1 (PRC1) to inhibit EMT, growth, proliferation, invasion, and migration in HCC cells in vitro, and mouse xenograft growth in vivo, which is Wnt/-dependent by biosignature analysis inactivation of catenin signaling (Zhang et al., 2019).